Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH ...
Results from Phase 3 ENERGIZE-T Study of Mitapivat in Transfusion-dependent Thalassemia will be Presented in Oral Session – – Tebapivat Phase 1 Data in Sickle Cell Disease and Phase 2b ...